Literature DB >> 2038731

Delivery of propellant soluble drug from a metered dose inhaler.

H L Ashworth1, C G Wilson, E E Sims, P K Wotton, J G Hardy.   

Abstract

The deposition of particulate suspensions delivered from a metered dose inhaler has been investigated extensively. The distribution of propellant, delivered from a metered dose inhaler, was studied by radiolabelling it with technetium-99m hexamethylpropyleneamine oxime. Andersen sampler measurements indicated that half of the dose was associated with particles in the size range 0.5-5 microns diameter. The preparation was administered to healthy subjects by inhalation and deposition was monitored with a gamma camera. Each lung image was divided into an inner, mid, and peripheral zone. The effects on deposition of varying the size of the delivery orifice (0.46, 0.61, and 0.76 mm internal diameters) and the effect of attaching a spacer were assessed. Lung deposition was independent of the orifice size within the actuator. Without the spacer the average dose deposited in the lungs was 39%, with 15% penetrating into the peripheral part of the lungs. Attachment of the spacer to the mouth-piece increased the mean lung deposition to 57% and reduced oropharyngeal deposition. The study has shown that propellant soluble drugs can be delivered efficiently to the lungs from a metered dose inhaler.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2038731      PMCID: PMC463087          DOI: 10.1136/thx.46.4.245

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  8 in total

1.  Technegas--a new ventilation agent for lung scanning.

Authors:  W M Burch; P J Sullivan; C J McLaren
Journal:  Nucl Med Commun       Date:  1986-12       Impact factor: 1.690

Review 2.  Conference on the scientific basis of respiratory therapy. Aerosol therapy. Aerosol characterization and deposition.

Authors:  P E Morrow
Journal:  Am Rev Respir Dis       Date:  1974-12

3.  Bronchodilator activity of a new inhaled beta 2-adrenoceptor agonist, tulobuterol and its protective effect in exercise-induced asthma.

Authors:  K R Patel
Journal:  Br J Clin Pharmacol       Date:  1986-02       Impact factor: 4.335

Review 4.  Therapeutic aerosols 1--physical and practical considerations.

Authors:  S P Newman; S W Clarke
Journal:  Thorax       Date:  1983-12       Impact factor: 9.139

5.  Quantitative comparison of 99Tcm-aerosol and 81Krm ventilation images.

Authors:  J E Agnew; R A Francis; D Pavia; S W Clarke
Journal:  Clin Phys Physiol Meas       Date:  1982-02

6.  Improvement of pressurised aerosol deposition with Nebuhaler spacer device.

Authors:  S P Newman; A B Millar; T R Lennard-Jones; F Morén; S W Clarke
Journal:  Thorax       Date:  1984-12       Impact factor: 9.139

7.  Autoradiographic visualization of beta-adrenoceptor subtypes in human lung.

Authors:  J R Carstairs; A J Nimmo; P J Barnes
Journal:  Am Rev Respir Dis       Date:  1985-09

8.  Deposition of pressurised aerosols in the human respiratory tract.

Authors:  S P Newman; D Pavia; F Morén; N F Sheahan; S W Clarke
Journal:  Thorax       Date:  1981-01       Impact factor: 9.139

  8 in total
  9 in total

Review 1.  Gamma scintigraphy in the evaluation of pharmaceutical dosage forms.

Authors:  S S Davis; J G Hardy; S P Newman; I R Wilding
Journal:  Eur J Nucl Med       Date:  1992

2.  Airway identification within planar gamma camera images using computer models of lung morphology.

Authors:  Jeffry D Schroeter; John N Pritchard; Dongming Hwang; Ted B Martonen
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

3.  Spray pattern analysis for metered dose inhalers: effect of actuator design.

Authors:  Hugh Smyth; Geoff Brace; Tony Barbour; Jim Gallion; Joe Grove; Anthony J Hickey
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

Review 4.  Nuclear medicine techniques in the evaluation of pharmaceutical formulations.

Authors:  A C Perkins; M Frier
Journal:  Pharm World Sci       Date:  1996-06

5.  Deposition patterns of aerosolized drugs within human lungs: effects of ventilatory parameters.

Authors:  T B Martonen; I M Katz
Journal:  Pharm Res       Date:  1993-06       Impact factor: 4.200

6.  Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction.

Authors:  R Melchor; M F Biddiscombe; V H Mak; M D Short; S G Spiro
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

7.  Formulation and in vitro evaluation of pressurized inhalation aerosols containing isotropic systems of lecithin and water.

Authors:  R M Evans; S J Farr; N A Armstrong; S M Chatham
Journal:  Pharm Res       Date:  1991-05       Impact factor: 4.200

Review 8.  Lung Deposition and Inspiratory Flow Rate in Patients with Chronic Obstructive Pulmonary Disease Using Different Inhalation Devices: A Systematic Literature Review and Expert Opinion.

Authors:  Adolfo Baloira; Araceli Abad; Antonia Fuster; Juan Luis García Rivero; Patricia García-Sidro; Eduardo Márquez-Martín; Marta Palop; Néstor Soler; J L Velasco; Fernando González-Torralba
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-04-19

9.  FIDEPOC: Consensus on Inspiratory Flow and Lung Deposition as Key Decision Factors in COPD Inhaled Therapy.

Authors:  Fernando González-Torralba; Adolfo Baloira; Araceli Abad; Antonia Fuster; Juan Luis García-Rivero; Patricia García-Sidro; Eduardo Márquez-Martín; Marta Palop; Néstor Soler; José Luis Velasco
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-05-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.